非小细胞肺癌高剂量放疗后支气管成形术与全肺切除术的比较
本研究回顾2008至2018年间27例接受根治性放化疗后 salvage 手术的非小细胞肺癌患者,其中全肺切除9例、肺叶切除18例(含支气管成形5例)。结果显示围手术期及远期结局可接受,90天死亡率为0%,R0切除是复发生存良好预后因素;支气管成形术组心律失常更常见。
要点
- 高剂量放化疗后 salvage 手术的围术期及远期结局可接受
- R0切除与更好的无复发生存相关
- 支气管成形术或全肺切除术可作为高剂量放化疗后的手术选择
核心结论
- 根治性放化疗后非小细胞肺癌 salvage 手术的围术期短期和长期结局可接受。
- 完全切除提供更好的无复发生存。
- 即使在高剂量放化疗后,支气管成形术或全肺切除术也应被视为一种选择。
研究设计与样本
- 回顾性研究,纳入2008至2018年间27例(21例男性;中位年龄61岁)根治性放化疗后接受 salvage 手术的非小细胞肺癌患者。
主要发现
- 中位放疗剂量为60 Gy。
- 从放疗最后一天至手术日的中位时间为8.5个月。
- 全肺切除术9例(含2例隆突切除),肺叶切除术18例(含5例支气管成形术)。
- 支气管包裹术9例(33%),R0切除24例(89%),术后并发症16例(59%)。
- 支气管胸膜瘘仅见于2例全肺切除术患者,心律失常在支气管成形术患者中更常见(P = .05);90天死亡率为0%;5年总生存率和无复发生存率分别为63%和27%;R0切除是无复发生存良好预后因素(P = .001)。
临床怎么用
- 对于根治性放化疗后的非小细胞肺癌患者,可考虑 salvage 手术,包括支气管成形术或全肺切除术。
- 应追求R0切除以改善无复发生存。
- 支气管成形术后需关注心律失常的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies have revealed that salvage surgery after definitive chemoradiotherapy (CRT) for unresectable advanced non-small cell lung cancer improves survival with acceptable surgical adverse events. Few reports exist regarding pneumonectomy or the bronchoplastic procedure in this setting. METHODS: Between 2008 and 2018, 27 patients (21 men; median age, 61 years) underwent salvage surgery after definitive CRT for non-small cell lung cancer. We investigated postoperative short- and long-term outcomes of salvage surgery and aimed to elucidate the feasibility of pneumonectomy or the bronchoplastic procedure. RESULTS: The median radiation dose was 60 Gy. The median period from the last day for irradiation to the operative day was 8.5 months. Pneumonectomy was performed in 9 patients, including 2 carinal resections; lobectomy was performed in 18 patients, including 5 bronchoplasties. Bronchial wrapping was performed in 9 cases (33%), R0 resection was achieved in 24 (89%), and postoperative complications were detected in 16 (59%). Although bronchopleural fistulas were found in only 2 patients who underwent pneumonectomy, arrhythmia was observed more frequently in patients who underwent the bronchoplastic procedure (P = .05). Regarding major complications, no relationship with any factors were found. The 90-day mortality was 0%. The 5-year overall and recurrence-free survival were 63% and 27%, respectively. R0 resection was a good prognostic factor for recurrence-free survival (P = .001). CONCLUSIONS: Perioperative short- and long-term outcomes of salvage surgery after definitive CRT for non-small cell lung cancer were acceptable. Complete resection offered a better recurrence-free survival. The bronchoplastic procedure or pneumonectomy should be considered as an option even after administration of high-dose CRT.
引用
- Watanabe Y, Suzuki K, Hattori A, et al. Bronchoplastic Procedure Versus Pneumonectomy After High-dose Radiation for Non-small Cell Lung Cancer. Ann Thorac Surg. 2020. PMID: 33359721. doi:10.1016/j.athoracsur.2020.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。